TrialJournal of diabetes investigation2024

Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes.

Yoshihiro Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.